GGrantIndex
Sort

326,823 grants matching clinical trial

IC-CSRisk Study: Implementation of Calculated Cesarean Section Risk during labor induction, a multi-site stepped-wedge randomized rollout trial

$1,918,854
Rebecca Feldman Hamm · University Of Pennsylvania · R01 · FY2023 · HD

Building blood based DNA methylation signatures for AD that are reflective of CNS changes

$1,918,750
Lily Wang · University Of Miami School Of Medicine · RF1 · FY2019 · AG

University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)

$1,918,750
H-H. Sherry Chow · University Of Arizona · UG1 · FY2021 · CA

University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)

$1,918,750
H-H. Sherry Chow · University Of Arizona · UG1 · FY2020 · CA

PHASE II CLINICAL TRIAL OF CELECOXIB (OR NSAID)

$1,918,721
Strang Cancer Prevention Center · N01 · FY2000 · CN

Human Immune Responses to Tumor Antigens for Cancer Immunotherapy

$1,918,695
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Mechanisms of Risk and Resilience in ASD: Ontogeny, Phylogeny and Gene Disruption

$1,918,453
Ami Klin · Emory University · P50 · FY2012 · MH

Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder

$1,918,419
Ali R Rezai · West Virginia University · UH3 · FY2022 · DA

1/3 Effectiveness Trial of the Early Social Interaction (ESI) Model using Mobile Technology for Toddlers with Autism Identified from Early Screening in Primary Care

$1,918,414
Amy M Wetherby · Florida State University · R01 · FY2022 · MH

Dissecting Heterogeneity of Treatment Response of First Episode Schizophrenia

$1,918,337
Anil K Malhotra · Feinstein Institute For Medical Research · P50 · FY2010 · MH

Overall Application: Trauma Primes Cells

$1,918,240
Anirban Banerjee · University Of Colorado Denver · P50 · FY2014 · GM

Molecular Diagnostics Core Laboratory

$1,918,162
Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA

Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation

$1,918,053
Munira Basrai · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARD

$1,918,043
Bruce Neil Cronstein · New York University School Of Medicine · UL1 · FY2010 · RR

DNA virus as vectors for cardiovascular diseases

$1,918,033
James M Wilson · University Of Pennsylvania · P01 · FY2012 · HL

First in Human Study of a Tau Self-Association Small Molecule Inhibitor in Healthy Volunteers

$1,917,889
William A. Erhardt · Oligomerix, Inc · R01 · FY2022 · AG

COVID-FIS: A PHASE 2 PLACEBO-CONTROLLED PILOT STUDY IN COVID-19 OF FISETIN TO ALLEVIATE DYSFUNCTION AND EXCESSIVE INFLAMMATORY RESPONSE IN OLDER ADULTS IN NURSING HOMES

$1,917,854
James L. Kirkland · Mayo Clinic Rochester · R01 · FY2020 · AG

ADULT AIDS CLINICAL TRIALS UNIT

$1,917,734
Case Western Reserve University · U01 · FY2001 · AI

Upper Gastrointestinal Cancer Studies

$1,917,700
Sanford M Dawsey · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA

Multi-Level Interventions to Reduce Caries Disparities in Primary Care Settings

$1,917,631
Suchitra S Nelson · Case Western Reserve University · UH3 · FY2021 · DE

Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer

$1,917,582
Estuardo Aguilar-Cordova · Advantagene, Inc · R44 · FY2012 · CA

BIOLOGICAL MARKERS OF BREAST CANCER &TAMOXIFEN RESPONSE

$1,917,538
University Of Pennsylvania · P01 · FY2004 · CA

CD40L adjuvanted clade C DNA and MVA HIV vaccines

$1,917,505
Rama Rao Amara · Emory University · U19 · FY2017 · AI

ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR AIDS

$1,917,303
Joseph J. Eron · Univ Of North Carolina Chapel Hill · U01 · FY2006 · AI

Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease

$1,917,246
Victor John Thannickal · University Of Alabama At Birmingham · P01 · FY2014 · HL